Full-Time

Senior Scientist / Associate Director

Oligonucleotide Therapeutics

Confirmed live in the last 24 hours

Insitro

Insitro

201-500 employees

Machine learning for drug discovery efficiency

AI & Machine Learning
Biotechnology

Compensation Overview

$150k - $200kAnnually

+ Annual Performance Bonus + Equity Incentive Plan

Senior

San Bruno, CA, USA

Hybrid role based in South San Francisco headquarters with occasional remote work and travel.

Category
Computational Biology
Genomics
Biology & Biotech
Requirements
  • PhD in biology, biochemistry or a relevant scientific subject area, with 2-4 years of relevant experience in the field of nucleic acid therapeutics is necessary for a Sr. Scientist role. For AD, a minimum of 4-6 years of post PhD with hands on experience of the key technical requirements is necessary
  • Deep understanding of mRNA biology/regulation, RNA structure, RNA folding, and RNA chemical modifications is required
  • Knowledge of siRNA/ASO/mRNA design and MOA is necessary
  • Knowledge and experience with assays such as Taqman, western, Ago2 loading assay, RNAscope, RNAseq, Ribosome profiling, oligo stability assays will be highly valuable
  • Understanding of oligonucleotide delivery technologies will be highly valuable
  • Understanding of oligonucleotide PK/PD and IVIVC will be good to have
  • Ability to multi-task and work across teams and disease areas will be needed
Responsibilities
  • Design siRNA/ASO/mRNA for drug discovery and target validation
  • Work closely with the therapeutic teams to design experiments (in-vitro/in-vivo) required for oligonucleotide drug discovery
  • Analyze data from oligonucleotide drug discovery programs (in-vitro and in-vivo efficacy, in-vivo pk/pd, off-target profile, and metID data)
  • Apply chemical modifications to enable oligonucleotide lead optimization SAR
  • Work with AI/ML scientists to develop oligonucleotide in-silico drug design tool
  • Understand target biology and come up with novel oligonucleotide based approaches to develop therapeutics
  • Analyze data, prepare graphs/tables, and present data to a wide range of audiences
  • Keep updated with the latest developments in the field of oligotherapy and nucleic acid drug discovery

Insitro focuses on drug discovery and development in the pharmaceutical research sector. The company utilizes machine learning and biological tools to create predictive models that help identify successful paths for developing new medicines. By doing so, Insitro aims to minimize the costly failures that often occur in pharmaceutical R&D. Their team, which includes scientists and engineers, collaborates to generate and analyze data to enhance the drug discovery process. Unlike traditional methods that rely heavily on intuition, Insitro's approach is data-driven and seeks to provide more accurate predictions. The company primarily serves pharmaceutical companies, healthcare providers, and research institutions looking for more efficient drug development solutions. Insitro's goal is to improve the overall effectiveness of drug discovery, ultimately leading to the successful development of new medicines.

Company Stage

Series C

Total Funding

$625.5M

Headquarters

San Francisco, California

Founded

2018

Growth & Insights
Headcount

6 month growth

8%

1 year growth

21%

2 year growth

48%
Simplify Jobs

Simplify's Take

What believers are saying

  • Insitro received $25 million from Bristol Myers Squibb for ALS target discovery.
  • The company raised over $600 million in venture capital funding.
  • Hiring Emily Fox enhances Insitro's AI and machine learning capabilities.

What critics are saying

  • Competition from well-funded companies like Xaira Therapeutics threatens Insitro's market position.
  • Ethical concerns in AI drug development could lead to regulatory scrutiny.
  • Dependence on milestone payments may cause financial instability if unmet.

What makes Insitro unique

  • Insitro integrates machine learning with high-throughput biology for drug discovery.
  • The company builds predictive models to accelerate target selection and drug development.
  • Insitro's approach aims to reduce expensive failures in pharmaceutical R&D.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Excellent medical, dental, and vision coverage

Excellent mental health and well-being support

Open vacation policy

Access to free onsite baristas & cafe with daily lunch and breakfast

Access to free onsite fitness center

Commuter benefits

Paid parental leave

Competitive pay and 401(k) matching

Flexible work schedule (on site and remote)